Skip to main content
SpringerLink
Log in

Potential drug–drug interactions in the medication of medical patients at hospital discharge

  • Pharmacoepidemiology and Prescription
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Objective

Information on the frequency of drug combinations with the potential to induce dangerous drug–drug interactions (DDIs) in patients discharged from the hospital is scarce. With the present study, we assessed the frequency and potential clinical significance of DDIs in the prescriptions of discharged medical patients.

Methods

We retrospectively screened the medication for potential DDIs of 500 patients consecutively discharged with at least two prescriptions using a computerised drug-interaction program.

Results

The 500 patients (56.6% male, mean age 67.0±15.9 years, median length of stay 13 days) were prescribed a median of six drugs (range 2–18) at discharge. Three hundred patients (60.0%; 95% confidence interval 55.7–64.3%) had at least one potentially interacting drug combination. Of 747 potential DDIs at discharge overall, 402 (53.8%) were new at the time of discharge due to a change of the medication during the hospital stay. Of these, 72 (17.9%) were of potentially minor, 281 (69.9%) of moderate and 49 (12.2%) of major severity. Of 44 patients with a potential DDI with major severity, 1 patient was re-hospitalised within 2 months after discharge due to a probable drug-related problem associated with the potential DDI.

Conclusions

Using a computerised drug-interaction program, a high proportion of patients was detected with at least one potential DDI in the medication prescribed at discharge. However, the proportion of DDIs associated with potentially relevant clinical consequences appeared to be relatively low.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gosney M, Tallis R (1984) Prescription of contraindicated and interacting drugs in elderly patients admitted to hospital. Lancet 2:564–567

    CAS  PubMed  Google Scholar 

  2. Mitchell GW, Stanaszek WF, Nichols NB (1979) Documenting drug–drug interactions in ambulatory patients. Am J Hosp Pharm 36:653–657

    CAS  PubMed  Google Scholar 

  3. Schneider JK, Mion LC, Frengley JD (1992) Adverse drug reactions in an elderly outpatient population. Am J Hosp Pharm 49:90–96

    CAS  PubMed  Google Scholar 

  4. Manchon ND, Bercoff E, Lemarchand P, Chassagne P, Senant J, Bourreille J (1989) Fréquence et gravité des interactions médicamenteuses dans une population agée: étude prospective concernant 639 malades. Rev Med Interne 10:521–525

    CAS  PubMed  Google Scholar 

  5. Costa AJ (1991) Potential drug interactions in an ambulatory geriatric population. Fam Pract 8:234–236

    CAS  PubMed  Google Scholar 

  6. Shinn AF, Shrewsbury RP, Anderson KW (1983) Development of a computerized drug interaction database (MEDICOM) for use in a patient specific environment. Drug Inf J 17:205–210

    CAS  PubMed  Google Scholar 

  7. Jankel CA, Fitterman LK (1993) Epidemiology of drug–drug interactions as a cause of hospital admissions. Drug Saf 9:51–59

    CAS  PubMed  Google Scholar 

  8. Raschetti R, Morgutti M, Menniti-Ippolito F, Belisari A, Rossignoli A, Longhini P et al (1999) Suspected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol 54:959–963

    Article  CAS  PubMed  Google Scholar 

  9. Heininger-Rothbucher D, Bischinger S, Ulmer H, Pechlaner C, Speer G, Wiedermann CJ (2001) Incidence and risk of potential adverse drug interactions in the emergency room. Resuscitation 49:283–288

    Article  CAS  PubMed  Google Scholar 

  10. Herr RD, Caravati EM, Tyler LS, Iorg E, Linscott MS (1992) Prospective evaluation of adverse drug interactions in the emergency department. Ann Emerg Med 21:1331–1336

    CAS  PubMed  Google Scholar 

  11. Wiesner C, Hersberger KE, Surber C, Haefeli WE (1999) Drug safety after hospital discharge. Pharm World Sci 22:A18

    Google Scholar 

  12. Grönroos PE, Irjala KM, Huupponen RK, Scheinin H, Forsstrom J, Forsstrom JJ (1997) A medication database—a tool for detecting drug interactions in hospital. Eur J Clin Pharmacol 53:13–17

    Article  PubMed  Google Scholar 

  13. Beers MH, Storrie M, Lee G (1990) Potential adverse drug interactions in the emergency room. An issue in the quality of care. Ann Intern Med 112:61–64

    CAS  PubMed  Google Scholar 

  14. Wiltink EH (1998) Medication control in hospitals: a practical approach to the problem of drug–drug interactions. Pharm World Sci 20:173–177

    Google Scholar 

  15. Bonetti PO, Hartmann K, Kuhn M, Reinhart WH, Wieland T (2000) Potentielle Arzneimittelinteraktionen und Verordnungshäufigkeit von Medikamenten mit speziellem Instruktionsbedarf bei Spitalaustritt. Schweiz Rundsch Med Prax 89:182–189

    CAS  PubMed  Google Scholar 

  16. Di Castri A, Jacquot JM, Hemmi P, Moati L, Rouy JM, Compan B et al (1995) Intéractions médicamenteuses: etudes de 409 ordonnances établies à l'issue d'une hospitalisation gériatrique. Therapie 50:259–264

    PubMed  Google Scholar 

  17. Köhler GI, Bode-Boger SM, Busse R, Hoopmann M, Welte T, Boger RH (2000) Drug–drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther 38:504–513

    PubMed  Google Scholar 

  18. Kruse W, Kohler J, Oster P, Schlierf G (1988) Potentielle Medikamentenwechselwirkungen in der Behandlung multimorbider Hochbetagter. Z Gerontol 21:164–168

    CAS  PubMed  Google Scholar 

  19. Smith L, McGowan L, Moss-Barclay C, Wheater J, Knass D, Chrystyn H (1997) An investigation of hospital generated pharmaceutical care when patients are discharged home from hospital. Br J Clin Pharmacol 44:163–165

    CAS  PubMed  Google Scholar 

  20. Atkinson AB, Brown JJ, Morton JJ, Leckie B, Fraser R, Lever AF et al (1979) Captopril in a hyponatraemic hypertensive: need for caution in initiating therapy. Lancet 1:557–558

    CAS  Google Scholar 

  21. Gluck Z, Beretta-Piccoli C, Reubi FC (1984) Long-term effects of captopril on renal function in hypertensive patients. Eur J Clin Pharmacol 26:315–323

    CAS  PubMed  Google Scholar 

  22. Romero R, Castellote E, Ocon J, Wagner B (1995) Controlled multicenter study with quinapril, hydrochlorothiazide, and combination in patients with moderate to severe hypertension. J Cardiovasc Pharmacol 26:114–118

    CAS  PubMed  Google Scholar 

  23. Nilsen OG, Sellevold OF, Romfo OS, Smedsrud A, Grynne B, Williams PE et al (1989) Pharmacokinetics and effects on renal function following cilazapril and hydrochlorothiazide alone and in combination in healthy subjects and hypertensive patients. Br J Clin Pharmacol 27:323S–328S

    CAS  PubMed  Google Scholar 

  24. Guazzi MD, Campodonico J, Celeste F, Guazzi M, Santambrogio G, Rossi M et al (1998) Antihypertensive efficacy of angiotensin converting enzyme inhibition and aspirin counteraction. Clin Pharmacol Ther 63:79–86

    Google Scholar 

  25. Mahe I, Meune C, Diemer M, Caulin C, Bergmann JF (2001) Interaction between aspirin and ACE inhibitors in patients with heart failure. Drug Saf 24:167–182

    CAS  PubMed  Google Scholar 

  26. Doman K, Perlmutter JA, Muhammedi M, Puschett JB (1993) Life-threatening hyperkalemia associated with captopril administration. South Med J 86:1269–1272

    CAS  PubMed  Google Scholar 

  27. Fuster D, Frey FJ, Ferrari P (2000) Bedrohliche Hyperkaliämie als Folge der neuen Behandlungsstrategien der Herzinsuffizienz. Schweiz Rundsch Med Prax 89:2073–2076

    CAS  PubMed  Google Scholar 

  28. Johnston RT, de Bono DP, Nyman CR (1992) Preventable sudden death in patients receiving angiotensin converting enzyme inhibitors and loop/potassium sparing diuretic combinations. Int J Cardiol 34:213–215

    CAS  PubMed  Google Scholar 

  29. Matthews MK Jr (1998) Association of Ginkgo biloba with intracerebral hemorrhage. Neurology 50:1933–1934

    PubMed  Google Scholar 

  30. Vale S (1998) Subarachnoid haemorrhage associated with Ginkgo biloba. Lancet 352:36

    CAS  Google Scholar 

  31. Rowin J, Lewis SL (1996) Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology 46:1775–1776

    CAS  PubMed  Google Scholar 

  32. Roberts JS, Watrous ML, Schulz RM, Mauch RP, Nightengale BS (1996) Quantifying the clinical significance of drug–drug interactions: scaling pharmacists' perceptions of a common interaction classification scheme. Ann Pharmacother 30:926–934

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Clinical Pharmacy, Department of Pharmacy, University of Basel, Basel, Switzerland

    Sabin S. Egger & Raymond G. Schlienger

  2. Division of Clinical Pharmacology and Toxicology, Department of Internal Medicine, University Hospital of Basel, 4031 , Basel, Switzerland

    Jürgen Drewe & Raymond G. Schlienger

Authors
  1. Sabin S. Egger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jürgen Drewe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Raymond G. Schlienger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Raymond G. Schlienger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Egger, S.S., Drewe, J. & Schlienger, R.G. Potential drug–drug interactions in the medication of medical patients at hospital discharge. Eur J Clin Pharmacol 58, 773–778 (2003). https://doi.org/10.1007/s00228-002-0557-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-002-0557-z

Keywords

Search

Navigation